Literature DB >> 9823314

Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment.

S R Kumari1, H Mendoza-Alvarez, R Alvarez-Gonzalez.   

Abstract

We have examined the domain-specific interactions between p53 and poly(ADP-ribose)polymerase (PARP) (E.C. 2.4.2.30) in apoptotic HeLa cells. Apoptosis was induced by exposing cells to 50 microM N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) for increasing lengths of time and was confirmed by: (a) oligonucleosomal fragmentation of chromatin; (b) increase in p53 levels; and (c) degradation of PARP into the characteristic M(r) 85,000 (COOH-terminal catalytic domain) and M(r) 29,000 (DNA-binding domain) peptide fragments. We also immunodetected p53 in immunoprecipitates obtained with a PARP-specific antibody. However, intact PARP coimmunoprecipitated with a p53-specific antibody during the initial 30 min of MNNG treatment. After 60 min, only the COOH-terminal fragment coimmunoprecipitated with p53, indicating that PARP noncovalently binds p53 via its M(r) 85,000 catalytic domain. Therefore, we next examined p53 as a covalent target for poly(ADP-ribosyl)ation. Although p53 was not endogenously poly (ADP-ribosyl)ated in situ, incubation of cell extracts with full-length PARP from calf thymus and [32P]beta NAD+ resulted in its time-dependent poly(ADP-ribosyl)ation. In summary, our results are consistent with the conclusion that PARP and p53 are activated with nonoverlapping kinetics during apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9823314

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

Review 1.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 2.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

Authors:  D D'Amours; S Desnoyers; I D'Silva; G G Poirier
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

3.  Genetic polymorphisms in key DNA repair genes and risk of head and neck cancer in a Chinese population.

Authors:  Hua Yuan; Huizhang Li; Hongxia Ma; Yuming Niu; Yunong Wu; Shangyue Zhang; Zhibin Hu; Hongbing Shen; Ning Chen
Journal:  Exp Ther Med       Date:  2012-02-09       Impact factor: 2.447

Review 4.  PARP and PARG inhibitors--new therapeutic targets in cancer treatment.

Authors:  Nilufer Jasmine Selimah Fauzee; Juan Pan; Ya-lan Wang
Journal:  Pathol Oncol Res       Date:  2010-04-12       Impact factor: 3.201

Review 5.  Poly(ADP-ribose) polymerase: the nuclear target in signal transduction and its role in brain ischemia-reperfusion injury.

Authors:  Robert Piotr Strosznajder; Henryk Jesko; Agata Zambrzycka
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 6.  How do I kill thee? Let me count the ways: p53 regulates PARP-1 dependent necrosis.

Authors:  Rana Elkholi; Jerry E Chipuk
Journal:  Bioessays       Date:  2013-10-24       Impact factor: 4.345

7.  Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2.

Authors:  Antony W Oliver; Jean-Christophe Amé; S Mark Roe; Valerie Good; Gilbert de Murcia; Laurence H Pearl
Journal:  Nucleic Acids Res       Date:  2004-01-22       Impact factor: 16.971

8.  p53 regulates a non-apoptotic death induced by ROS.

Authors:  J Montero; C Dutta; D van Bodegom; D Weinstock; A Letai
Journal:  Cell Death Differ       Date:  2013-05-24       Impact factor: 15.828

9.  Dual regulation of AP-2alpha transcriptional activation by poly(ADP-ribose) polymerase-1.

Authors:  Min Li; Padmavathy Naidu; Yihong Yu; Nathan A Berger; Perry Kannan
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

10.  RNAa is conserved in mammalian cells.

Authors:  Vera Huang; Yi Qin; Ji Wang; Xiaoling Wang; Robert F Place; Guiting Lin; Tom F Lue; Long-Cheng Li
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.